By using reinforcement learning, researchers train virtual agent to determine the best time to administer medication based on ...

With Thanksgiving just around the corner, vector-borne diseases like anaplasmosis are probably not top of mind for midwestern ...

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, announced today that findings from a post hoc analysis of its Phase 2 RESCUE ...

FYR Bio ("FYR"), a leader in liquid-biopsy precision medicine for neuro-oncology, today announced a collaboration with NuvOx Therapeutics, Inc. ("NuvOx") supported by a two-year $1,976,897 ...

Discover seven plants that can enhance your sleep quality through natural means. From the calming scent of lavender and ...

Exercise equipment, gym accessories, workout tech and more — we rounded up the best fitness gifts for treating someone who ...

Mumbai: In a remarkable medical achievement, a micro-preemie born at just 23 weeks and 6 days, weighing only 690 grams, has ...

Pertussis, or whooping cough, remains a highly contagious respiratory infection caused by Bordetella pertussis . Despite ...

Agios Pharmaceuticals, Inc. drops after mixed Phase 3 mitapivat results in Sickle Cell Disease. Click here to find out why ...

It will unfold alongside the G20 Leaders Summit, creating a two-tier stage where economic and health decisions mingle, ...

My 86-year-old father was recently hospitalized with a severe infection. We were told he’s at an increased risk for sepsis ...

The firms will use the funds to integrate FYR's liquid biopsy platform in NuvOx's Phase II trial evaluating the oxygen therapeutic NanO₂ as a radiosensitizer.